vaccine tests on French volunteers will begin in a few days

In recent weeks, the French research agency Inserm has received the registrations of 41,000 volunteers ready to receive the first draft of vaccines against the coronavirus before their commercialization to evaluate their effectiveness and tolerance in humans. The results of these tests in France will add to those already obtained by manufacturers in the rest of the world.

Among the three laboratories that have entered into an agreement with Inserm, there is AstraZeneca. 1,000 French volunteers will test his vaccine project. The trial is expected to begin within ten days at the same time as another trial on the Janssen vaccine project, this time, including 1,000 French participants. Janssen begins his stage 3 test, the last.

Each time, the volunteers will be given the vaccine project or a placebo. They will live normally and researchers will observe if they are infected with Covid, if they have a severe form of the disease and if they are suffering from side effects. “There is immediate surveillance after vaccination and then we see the participants again. And then there is a more prolonged surveillance that lasts from one to two years, where we ask the participants to inform us of all the events that are happening to them. arrived “, explains Professor Odile Launay, who coordinates this French vaccination platform.

A third trial is expected to begin within a month, with most volunteers over the age of 70. They will test the Modern American vaccine project. The goal is to find out if the product protects the elderly as much as others.